221 related articles for article (PubMed ID: 10845739)
1. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
Mohamed K; Appleton R; Rosenbloom L
Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
[TBL] [Abstract][Full Text] [Related]
2. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
3. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
[TBL] [Abstract][Full Text] [Related]
5. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects.
Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A
Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081
[TBL] [Abstract][Full Text] [Related]
6. Topiramate slow dose titration: improved efficacy and tolerability.
Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
[TBL] [Abstract][Full Text] [Related]
7. Topiramate for drug-resistant epilepsies.
Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
[TBL] [Abstract][Full Text] [Related]
8. Topiramate for intractable childhood epilepsy.
Moreland EC; Griesemer DA; Holden KR
Seizure; 1999 Feb; 8(1):38-40. PubMed ID: 10091847
[TBL] [Abstract][Full Text] [Related]
9. Topiramate: efficacy and tolerability in children according to epilepsy syndromes.
Mikaeloff Y; de Saint-Martin A; Mancini J; Peudenier S; Pedespan JM; Vallée L; Motte J; Bourgeois M; Arzimanoglou A; Dulac O; Chiron C
Epilepsy Res; 2003 Mar; 53(3):225-32. PubMed ID: 12694931
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
Al Ajlouni S; Shorman A; Daoud AS
Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of topiramate in children younger than 2 years old.
Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
[TBL] [Abstract][Full Text] [Related]
14. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
15. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents.
Glauser TA; Dlugos DJ; Dodson WE; Grinspan A; Wang S; Wu SC;
J Child Neurol; 2007 Jun; 22(6):693-9. PubMed ID: 17641254
[TBL] [Abstract][Full Text] [Related]
16. Effect of topiramate on intractable seizures in Taiwanese children.
Li ST; Shen EY; Chiu NC; Ho CS
Acta Neurol Taiwan; 2004 Jun; 13(2):59-63. PubMed ID: 15478676
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of topiramate in children.
Levisohn PM
J Child Neurol; 2000; 15 Suppl 1():S22-6. PubMed ID: 11218053
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions of Topiramate and Lamotrigine in children.
Shechter T; Shorer Z; Kramer U; Lerman-Sagie T; Ronen E; Rotem R; Gorodischer R
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):187-92. PubMed ID: 15517533
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
